News|Articles|October 15, 2025

Avantor Technical Note: Column Selection For Peptide and Protein RPLC Separations in Biopharmaceutical Analysis

Author(s)Avantor

This article focuses on the important column selection decisions that are required for reversed-phase separations involving large biomolecules such as proteins.


Related to this article

Debunking Myths and Half-Truths in HPLC and Pharmaceutical Analysis
"Perspectives in HPLC" examines 5 long-held HPLC "rules" (mobile phase filtration, routine buffer use, avoiding pH near an analyte's pKa, defaulting to 4.6-mm columns, and relying on AI for early method development), showing with experimental evidence that each is conditional rather than universally true in modern small-molecule drug testing.